G&S Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
G&S Capital's AMGN Position: Q3 2026 in Review
G&S Capital reduced its Amgen (AMGN) stake by 0.64% in Q3 2026, selling an estimated $11.2K and leaving 4,331 shares worth $1.83M. The position accounts for 0.53% of the portfolio, ranked #59.
G&S Capital first reported a position in AMGN in Q4 2017 and has held it in 4 quarters since. The position peaked at $3.06M in Q4 2017. 2,617 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- G&S Capital held 4,331 shares of Amgen worth $1.83M as of Q3 2026.
- G&S Capital sold 28 Amgen shares in Q3 2026, an estimated $11.2K.
- Amgen made up 0.53% of G&S Capital's portfolio in Q3 2026, its #59 holding.
- G&S Capital first reported a position in Amgen in Q4 2017 and has held it in 4 quarters since.
- G&S Capital's Amgen position peaked at $3.06M in Q4 2017.
- 2,617 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on G&S Capital's 13F filing for Q3 2026, filed 23 Oct 2026.